Company Filing History:
Years Active: 2020-2024
Title: Innovations in Depression Treatment by Margaret Fedgchin
Introduction
Margaret Fedgchin is a prominent inventor based in Collegeville, PA (US), known for her significant contributions to the field of mental health treatment. With a total of four patents to her name, she has focused her research on innovative methods for treating depression, particularly in patients who are resistant to traditional therapies.
Latest Patents
Among her latest patents is a groundbreaking invention involving esketamine for the treatment of depression. This invention outlines methods for administering a therapeutically effective amount of esketamine to patients suffering from major depressive disorder or treatment-resistant depression. The patent also includes strategies to mitigate the risks of misuse or abuse of esketamine, along with detailed instructions for its use and methods for marketing the drug product. Another notable patent focuses on various methods and dosing regimens for treating depression, especially in suicidal patients, aiming to prevent suicidality and improve patient outcomes.
Career Highlights
Margaret has made significant strides in her career, working with Janssen Pharmaceutica NV, a leading company in pharmaceutical innovation. Her work has been instrumental in advancing treatment options for individuals struggling with depression, showcasing her dedication to improving mental health care.
Collaborations
Throughout her career, Margaret has collaborated with talented professionals, including Jaskaran Singh and Ella Daly. These partnerships have contributed to the development of her innovative patents and have enhanced the impact of her work in the field.
Conclusion
Margaret Fedgchin's contributions to the treatment of depression through her innovative patents highlight her commitment to advancing mental health care. Her work continues to pave the way for new therapeutic options, making a significant difference in the lives of patients.